| 763858 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
774 An induced pluripotent stem cell (iPSC) vaccine is highly immunogenic and reduces lung metastases in a mouse model of melanoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.774 |
Hundt Matthias, Bove Peter, Hernandez Ivan, Li Michelle, Beviglia Lucia, Kundu Pratima, Ndoye Babacar, Kooreman Nigel, Wolpe Stephen, Bui Lynne |
| 763857 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
556 Chemo-immunotherapy to treat bone-metastatic prostate cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.556 |
Kumar Shreya, Figueiredo Marxa |
| 763856 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
530 A first-in-human phase I study of M6223 (TIGIT inhibitor) as monotherapy or in combination with bintrafusp alfa in patients with metastatic or locally advanced solid unresectable tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.530 |
Watson Geoffrey, McKean Meredith, Tolcher Anthony, Victor Anja, Zhang Sen, Pierre Vadryn, Richter Emilia, Naing Aung, Naing Aung |
| 763855 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
436 A phase II study of AK104, a bispecific antibody targeting PD-1 and CTLA-4, in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.436 |
Mai Haiqiang, Lin Shaojun, Chen Dongping, Chen Xiaozhong, Qu Song, Lin Qin, Luo Ying, Hu Chunhong, Wu Dehua, Qin Tianxin, Jin Feng, Chen Nianyong, Luo Yunxiu, Yao Zhifang, Jin Xiaoping, Li Baiyong, Xia Yu, Xu Rui-Hua |
| 763854 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
76 Spatial mapping of T cell receptors and transcriptomes in renal cell carcinoma following immune checkpoint inhibitor therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.076 |
Liu Sophia, Iorgulescu Bryan, Li Shuqiang, Morriss Julia, Borji Mehdi, Murray Evan, Braun David, Livak Kenneth, Wu Catherine, Chen Fei |
| 763853 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
305 Unravelling the role of CD4+ and CD8+ T cells in pembrolizumab induced mycobacterium tuberculosis granuloma formation in nasopharyngeal carcinoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.305 |
Desmond Hung Tae Yang, Kam Ngar Woon, Fun Lee Victor Ho |
| 763852 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
74 Tumor microenvironment based on PD-L1 and CD8 T-cell infiltration correlated with the response of MSS mCRC patients treated vactosertib in combination with pembrolizumab |
2021-11-01 |
10.1136/jitc-2021-sitc2021.074 |
Kim Tae Won, Lee Keun-Wook, Ahn Joong Bae, Park Young Suk, Ock Chan-Young, Park Hyejoo, Ryu Jiyeon, Oh Bitna, Kim Bo-Kyoung, Hwang Sunjin, Hahm Ki Baik, Kim Seong-Jin |
| 763851 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
559 Preclinical evaluation of pegylated liposomal Doxorubicin or Doxorubicin with mATRC-101 in the EMT6 syngeneic mouse model |
2021-11-01 |
10.1136/jitc-2021-sitc2021.559 |
Zhang Danhui, Vad Nikhil, Wechsler Erin |
| 763850 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
9 BRAF mutations are associated with T-helper cell infiltration and polarization in melanoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.009 |
Ware Michael, Pavuluri Bhavana, Smith Aubrey, Wyatt Megan, RIvera Guillermo Rangel, Cole Anna, Paulos Chrystal |
| 763849 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
175 High-dose TIL product with improved phenotype and functionality |
2021-11-01 |
10.1136/jitc-2021-sitc2021.175 |
Friese Christina, Heeke Christina, Kirketerp-Møller Nikolaj, Færch Sandra, Nielsen Maria Juul, Hey Amalie, Cordes Ulrik |
